-
SAN ANTONIO — A clinical validation study in a general population of patients who had undergone breast-conserving surgery for ductal carcinoma in situ (DCIS) has shown that the 12-gene Oncotype DX DCIS Score (Genomic Health) is good at predicting whether […]
read more -
SAN ANTONIO — Screening ultrasound in addition to mammography should be routine for women with dense breast tissue, according to a study from Connecticut, where the first breast density notification law was passed. The positive predictive value of screening […]
read more -
Patients with early-stage breast cancer treated with preventive or adjuvant chemotherapy face an increased risk for leukemia that does not justify the modest survival benefit of additional treatment, say US researchers. They found that early-stage breast cancer patients treated […]
read more -
(Reuters Health) – Women’s self-exams and physical exams by a doctor both detect breast cancer tumors at about the same size, but older women are more likely to have a tumor discovered via doctor’s examination, according to a new Swiss […]
read more -
Deaths from cancer continue to fall in the United States, and the American Cancer Society (ACS) estimates that the 22% drop in cancer mortality seen during the last 2 decades has resulted in more than 1.5 million cancer deaths being […]
read more -
Researchers have found excessive levels of formaldehyde, an established carcinogen, in the vapor produced by e-cigarettes when the devices are used at high voltage. The cancer risk from this unexpected finding is much greater than from conventional cigarettes. This finding […]
read more -
MADRID — Final results from the CLEOPATRA study show that the combination of 2 targeted agents, trastuzumab (Herceptin, Roche/Genentech) and pertuzumab (Perjeta, Roche/Genentech), significantly prolonged survival in HER2-positive metastatic breast cancer, compared with trastuzumab alone. The targeted agents were added […]
read more -
A breast biopsy that results in a diagnosis of atypical hyperplasia is considered a benign finding, but that description obscures the riskiness of the condition, according to a special report published in the January 1, 2015, issue of the New […]
read more -
Women with breast cancer often don’t know what kind of tumors they have, a new study found. That’s not necessarily tied to worse outcomes, but better knowledge might help women understand treatment decisions and take medications as directed, said […]
read more -
Adherence to diabetes drugs falls after a diagnosis of cancer, a new study finds. The results suggest that drop-offs in compliance with diabetes medication might negatively affect survival and could therefore partly explain the established higher cancer mortality seen […]
read more
